Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Mahnken

Showing results (11-20 of 136) with videos related to

Pageof 14
Sort By:
Journal of Biopharmaceutical Statistics|January 16, 2010
Optimal designs for two-arm, phase II clinical trial design with multiple constraintsMatthew S Mayo, Jonathan D Mahnken, Seng-Jaw Soong
BMC Nephrology|September 23, 2016
Association of multiple ischemic strokes with mortality in incident hemodialysis patients: an application of multistate model to determine transition probabilities in a retrospective observational cohortJames B Wetmore, Jonathan D Mahnken, Milind A Phadnis
BMC Medical Research Methodology|July 10, 2012
Simultaneous evaluation of abstinence and relapse using a Markov chain model in smokers enrolled in a two-year randomized trialHung-Wen Yeh, Edward F Ellerbeck, Jonathan D Mahnken
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|April 17, 2014
Derivation and validation of a formula to estimate risk for 30-day readmission in medical patientsMohammad Taha, Aroop Pal, Jonathan D Mahnken, et al.
BMC Medical Research Methodology|August 23, 2011
The Box-Cox power transformation on nursing sensitive indicators: does it matter if structural effects are omitted during the estimation of the transformation parameter?Qingjiang Hou, Jonathan D Mahnken, Byron J Gajewski, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|May 22, 2009
Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observationsCharles W Butrick, Dan Sanford, Qingijiang Hou, et al.
Pharmaceutical Statistics|August 12, 2016
Generalized optimal design for two-arm, randomized phase II clinical trials with endpoints from the exponential dispersion familyWei Jiang, Jonathan D Mahnken, Jianghua He, et al.
Research in Social & Administrative Pharmacy : RSAP|September 5, 2021
Trajectories of glycemic control with clinical pharmacy specialist management of veterans with type 2 diabetesTed R Grabarczyk, Andrew W Roberts, Jonathan D Mahnken, et al.
Statistical Methods in Medical Research|May 1, 2008
Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approachJonathan D Mahnken, Wenyaw Chan, Daniel H Freeman, et al.
Journal of Cardiothoracic and Vascular Anesthesia|October 6, 2005
Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgeryKenneth R Kreisler, Robert A Vance, Jose Cruzzavala, et al.
Pageof 14

Showing results (11-20 of 136) with videos related to

Sort By:
Pageof 14
Journal of Biopharmaceutical Statistics|January 16, 2010
Optimal designs for two-arm, phase II clinical trial design with multiple constraintsMatthew S Mayo, Jonathan D Mahnken, Seng-Jaw Soong
BMC Nephrology|September 23, 2016
Association of multiple ischemic strokes with mortality in incident hemodialysis patients: an application of multistate model to determine transition probabilities in a retrospective observational cohortJames B Wetmore, Jonathan D Mahnken, Milind A Phadnis
BMC Medical Research Methodology|July 10, 2012
Simultaneous evaluation of abstinence and relapse using a Markov chain model in smokers enrolled in a two-year randomized trialHung-Wen Yeh, Edward F Ellerbeck, Jonathan D Mahnken
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|April 17, 2014
Derivation and validation of a formula to estimate risk for 30-day readmission in medical patientsMohammad Taha, Aroop Pal, Jonathan D Mahnken, et al.
BMC Medical Research Methodology|August 23, 2011
The Box-Cox power transformation on nursing sensitive indicators: does it matter if structural effects are omitted during the estimation of the transformation parameter?Qingjiang Hou, Jonathan D Mahnken, Byron J Gajewski, et al.
International Urogynecology Journal and Pelvic Floor Dysfunction|May 22, 2009
Chronic pelvic pain syndromes: clinical, urodynamic, and urothelial observationsCharles W Butrick, Dan Sanford, Qingijiang Hou, et al.
Pharmaceutical Statistics|August 12, 2016
Generalized optimal design for two-arm, randomized phase II clinical trials with endpoints from the exponential dispersion familyWei Jiang, Jonathan D Mahnken, Jianghua He, et al.
Research in Social & Administrative Pharmacy : RSAP|September 5, 2021
Trajectories of glycemic control with clinical pharmacy specialist management of veterans with type 2 diabetesTed R Grabarczyk, Andrew W Roberts, Jonathan D Mahnken, et al.
Statistical Methods in Medical Research|May 1, 2008
Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approachJonathan D Mahnken, Wenyaw Chan, Daniel H Freeman, et al.
Journal of Cardiothoracic and Vascular Anesthesia|October 6, 2005
Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgeryKenneth R Kreisler, Robert A Vance, Jose Cruzzavala, et al.
Pageof 14